Greenwich LifeSciences (NASDAQ:GLSI) Given Buy Rating at HC Wainwright

Greenwich LifeSciences (NASDAQ:GLSI – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in a research note issued on Tuesday,Benzinga reports. They presently have a $38.00 price objective on the stock. HC Wainwright’s price objective would indicate a potential upside of 217.46% from the stock’s current price. Greenwich LifeSciences […]